The feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer.

Dillman, R O; Nayak, S K; Brown, J V; Mahdavi, K; Beutel, L D

Dillman, R O; Nayak, S K; Brown, J V; Mahdavi, K; Beutel, L D.

Affiliation

Dillman RO; Hoag Cancer Center, Newport Beach, California 92658, USA. rdillman@hoaghospital.org

Cancer Biother Radiopharm ; 14(6): 443-9, 1999 Dec.

Article in En | MEDLINE | ID: mdl-10850331

Subject(s)

Cancer Vaccines; Ovarian Neoplasms/pathology; Ovarian Neoplasms/therapy; Aged; Cell Culture Techniques/methods; Cell Division; Cell Transplantation; Feasibility Studies; Female; Humans; Neoplasm Staging; Ovarian Neoplasms/immunology; Transplantation, Autologous; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cancer Vaccines Limits: Aged / Female / Humans Language: En Journal: Cancer Biother Radiopharm Journal subject: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links